Anna Aureli, PhD Institute of Translational Pharmacology (IFT) National Research Council of Italy (CNR) Via Fosso del Cavaliere 100, 00133 Rome, Italy E-mail: anna.aureli@cnr.it Current Position 2001-present: Researcher, Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR), Italy. Previous Positions 2020-2026: Delegate Head of the L'Aquila Unit, Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR), Italy. Current Affiliation Since 2026: Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR), Rome, Italy. Research Activities Research activities focus on molecular biology, genetics, and translational neuroscience, with particular expertise in mitochondrial dysfunction, oxidative stress, neuroinflammation, and biomarker discovery. Current research investigates the molecular mechanisms linking neurodevelopment, aging, and neurodegeneration, with special emphasis on microbiome-host interactions, the microbiome-gut-brain axis, mitochondrial quality control, and precision medicine approaches. Additional research interests include immunogenetics, HLA-associated disease susceptibility, cancer immunomodulation, and translational approaches for complex disorders. Memberships European Federation for Immunogenetics (EFI)